FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013021713> ?p ?o ?g. }

• W3013021713 abstract "The most common management strategy for tinnitus provided in the UK audiology clinics is education and advice. This may also be combined with some form of sound therapy (e.g. digital hearing aids). While education and advice is generally provided by all clinics, there is a marked variability in provision of hearing aids that depends very much on clinical decisions. A recent Cochrane review concluded a lack of evidence to support or refute hearing aid use as a routine intervention for people with tinnitus and hearing loss. This lack of evidence is reflected in the inconsistency of tinnitus management in the UK. The aim of the HUSH trial is to determine the feasibility of conducting a definitive randomised controlled trial (RCT) of the effectiveness and cost-effectiveness of hearing aids for adults with tinnitus and hearing loss.This is a multicentre randomised controlled feasibility trial. Up to 100 adults, aged 18 and over, presenting to 5 UK audiology clinics with a complaint of tinnitus and measurable hearing loss are being randomised to receive either (i) education and advice (treatment as usual) or (ii) education and advice with digital hearing aids. Feasibility outcomes are being collected around recruitment, retention, patient and healthcare professional acceptability and clinical outcome assessment. Outcomes are being collected via postal questionnaire at 12 weeks post baseline. A nested interview study will supplement clinical and other outcome data, providing a detailed understanding of participants' and audiologists' experience of both tinnitus management and the research processes.This feasibility trial will help us to (i) determine if it is feasible to conduct a multicentre RCT comparing treatment as usual and treatment as usual plus digital hearing aids; (ii) optimise the design of a future definitive, multicentre RCT; and (iii) inform which outcome(s) is/are relevant for patients. This work presents an important first step in determining the effectiveness of hearing aids as a tinnitus management strategy.ISRCTN, ISRCTN14218416. Registered on 30 July 2018." @default.
• W3013021713 created "2020-04-03" @default.
• W3013021713 creator A5003316836 @default.
• W3013021713 creator A5019271003 @default.
• W3013021713 creator A5036629717 @default.
• W3013021713 creator A5043407054 @default.
• W3013021713 creator A5055634988 @default.
• W3013021713 creator A5060377511 @default.
• W3013021713 creator A5066910927 @default.
• W3013021713 creator A5069220303 @default.
• W3013021713 creator A5069415094 @default.
• W3013021713 creator A5075164186 @default.
• W3013021713 creator A5077659318 @default.
• W3013021713 creator A5081827722 @default.
• W3013021713 date "2020-03-27" @default.
• W3013021713 modified "2023-09-26" @default.
• W3013021713 title "Protocol for a multi-centre randomised controlled stand-alone feasibility trial to assess potential effectiveness and cost-effectiveness of digital hearing aids in patients with tinnitus and hearing loss (the HUSH trial)" @default.
• W3013021713 cites W1585551982 @default.
• W3013021713 cites W1845447069 @default.
• W3013021713 cites W1885489887 @default.
• W3013021713 cites W1964459106 @default.
• W3013021713 cites W1976770755 @default.
• W3013021713 cites W1979711714 @default.
• W3013021713 cites W1990166011 @default.
• W3013021713 cites W2005938241 @default.
• W3013021713 cites W2013486245 @default.
• W3013021713 cites W2018968507 @default.
• W3013021713 cites W2029491724 @default.
• W3013021713 cites W2037248165 @default.
• W3013021713 cites W2045675884 @default.
• W3013021713 cites W2051883403 @default.
• W3013021713 cites W2054921073 @default.
• W3013021713 cites W2074369546 @default.
• W3013021713 cites W2108696783 @default.
• W3013021713 cites W2140215977 @default.
• W3013021713 cites W2157353132 @default.
• W3013021713 cites W2166281097 @default.
• W3013021713 cites W2326345919 @default.
• W3013021713 cites W2415005901 @default.
• W3013021713 cites W2508065595 @default.
• W3013021713 cites W2534656414 @default.
• W3013021713 cites W2588720584 @default.
• W3013021713 cites W2589186540 @default.
• W3013021713 cites W2602918391 @default.
• W3013021713 cites W2747626400 @default.
• W3013021713 cites W2767728269 @default.
• W3013021713 cites W2787517427 @default.
• W3013021713 cites W2885350553 @default.
• W3013021713 cites W2902904926 @default.
• W3013021713 cites W2908315352 @default.
• W3013021713 cites W2914933913 @default.
• W3013021713 cites W3162993738 @default.
• W3013021713 cites W4206586963 @default.
• W3013021713 cites W4236805817 @default.
• W3013021713 cites W4366076260 @default.
• W3013021713 cites W4378882291 @default.
• W3013021713 doi "https://doi.org/10.1186/s40814-020-00582-5" @default.
• W3013021713 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7099812" @default.
• W3013021713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32231789" @default.
• W3013021713 hasPublicationYear "2020" @default.
• W3013021713 type Work @default.
• W3013021713 sameAs 3013021713 @default.
• W3013021713 citedByCount "2" @default.
• W3013021713 countsByYear W30130217132022 @default.
• W3013021713 crossrefType "journal-article" @default.
• W3013021713 hasAuthorship W3013021713A5003316836 @default.
• W3013021713 hasAuthorship W3013021713A5019271003 @default.
• W3013021713 hasAuthorship W3013021713A5036629717 @default.
• W3013021713 hasAuthorship W3013021713A5043407054 @default.
• W3013021713 hasAuthorship W3013021713A5055634988 @default.
• W3013021713 hasAuthorship W3013021713A5060377511 @default.
• W3013021713 hasAuthorship W3013021713A5066910927 @default.
• W3013021713 hasAuthorship W3013021713A5069220303 @default.
• W3013021713 hasAuthorship W3013021713A5069415094 @default.
• W3013021713 hasAuthorship W3013021713A5075164186 @default.
• W3013021713 hasAuthorship W3013021713A5077659318 @default.
• W3013021713 hasAuthorship W3013021713A5081827722 @default.
• W3013021713 hasBestOaLocation W30130217131 @default.
• W3013021713 hasConcept C112930515 @default.
• W3013021713 hasConcept C141071460 @default.
• W3013021713 hasConcept C142724271 @default.
• W3013021713 hasConcept C159110408 @default.
• W3013021713 hasConcept C168563851 @default.
• W3013021713 hasConcept C1862650 @default.
• W3013021713 hasConcept C2776992516 @default.
• W3013021713 hasConcept C2780493683 @default.
• W3013021713 hasConcept C2780665704 @default.
• W3013021713 hasConcept C2780801066 @default.
• W3013021713 hasConcept C3019080777 @default.
• W3013021713 hasConcept C512399662 @default.
• W3013021713 hasConcept C535046627 @default.
• W3013021713 hasConcept C548259974 @default.
• W3013021713 hasConcept C71924100 @default.
• W3013021713 hasConceptScore W3013021713C112930515 @default.
• W3013021713 hasConceptScore W3013021713C141071460 @default.
• W3013021713 hasConceptScore W3013021713C142724271 @default.
• W3013021713 hasConceptScore W3013021713C159110408 @default.
• W3013021713 hasConceptScore W3013021713C168563851 @default.
• W3013021713 hasConceptScore W3013021713C1862650 @default.
• W3013021713 hasConceptScore W3013021713C2776992516 @default.

• next